Week six marks the end of the purging window
Vasorelaxant effect of glucagon-like peptide-7-36/amide and amylin on the pulmonary circulation of the rat
GLP-1 medications can significantly reduce appetite and energy intake, which may lead to: In many cases, people using GLP-1 medications outside of medical supervision may not understand the risk to their health, including the impact on exercise and nutrition
Instead of injecting weekly, you move to every 10 days, then every 2 weeks, then every 3 weeks, then stop
in addition, NO inhibits platelet function
Further investigations of the relevant mechanisms have indicated that GLP-1 acts on bone tissue by promoting bone formation and inhibiting bone resorption